IP Library › Granted Patent US 8,168,191
Granted Patent B2
US 8,168,191 · App. 12/113,822 · Granted May 1, 2012

Cytotoxic T lymphocyte

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,168,191
App. No.
12/113,822
Granted
May 1, 2012
Kind
B2
Abstract

The present invention relates to a T lymphocyte having an activity to induce a T lymphocyte recognizing an antigen and a technique to use the T lymphocyte.

Claims (2)

1. An inducer of a cytotoxic T lymphocyte containing an isolated human major histo-compatibility antigen (HLA)-A24-restricted antigen peptide consisting of SEQ ID NO: 2 as an active ingredient.

2. A tetramer for detecting a T cell receptor possessed by a cytotoxic T lymphocyte, comprising an isolated human major histo-compatibility antigen (HLA)-A24-restricted antigen peptide consisting of SEQ ID NO: 2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2019
From: TAKARA BIO INC.
To: MIE UNIVERSITY
Reel/Frame 050213/0980 →
CHANGE OF ADDRESS Recorded Jun 24, 2016
From: TAKARA BIO INC.
To: TAKARA BIO INC.
Reel/Frame 039152/0834 →